The fourth shot of the COVID-19 vaccine boosts antibodies but doesn’t provide enough protection to prevent infections from the Omicron variant, according to new research at an Israeli hospital.
The preliminary results, released on Monday, challenge the idea of giving a second booster dose to slow the spread of the coronavirus, according to USA Today.
Despite increased antibody levels, the fourth vaccine only offers a partial defense against the virus.
In a clinical trial, 274 medical workers at Sheba Medical Center near Tel Aviv received a fourth vaccine dose in December -- 154 got the Pfizer vaccine and 120 got the Moderna vaccine -- after previously getting three Pfizer shots.
Both groups received a boost in antibodies that was “slightly higher” than after the third shot, Regev-Yochay said. But when compared to a control group that didn’t receive the fourth dose, the extra boost didn’t prevent the spread of Omicron.
Let us invest in a different, Covid tweaked vaccines that target the virus, instead of keep boosting people unnecessary. Just a thought.
No comments:
Post a Comment